Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Thorax|October 28, 2017
Exacerbation risk and characterisation of the UK's asthma population from infants to old ageChloe I Bloom, Francis Nissen, Ian J Douglas, et al.
Journal of Comparative Effectiveness Research|May 10, 2022
Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia AArash Mahajerin, Imi Faghmous, Peter Kuebler, et al.
Orphanet Journal of Rare Diseases|January 13, 2025
An assessment of burden associated with problem joints in children and adults with moderate or severe haemophilia A: analysis of the CHESS-Paediatrics and CHESS II cross-sectional studiesPaul McLaughlin, Hortensia De la Corte-Rodriguez, Tom Burke, et al.
Research and Practice in Thrombosis and Haemostasis|May 30, 2024
Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping reviewGuy Young, Steven W Pipe, Gili Kenet, et al.
Journal of Asthma and Allergy|January 22, 2019
Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)Francis Nissen, Ian J Douglas, Hana Müllerová, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 8, 2023
Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature reviewPier Mannuccio Mannucci, Craig M Kessler, Federico Germini, et al.
Journal of Asthma and Allergy|January 7, 2021
Revisiting Late-Onset Asthma: Clinical Characteristics and Association with AllergySantiago Quirce, Enrico Heffler, Natalia Nenasheva, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|April 17, 2024
Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDsPratima Chowdary, Richard Ofori-Asenso, Francis Nissen, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Pageof 2